Centervue, a part of the Revenio Group, is a trusted provider of cutting-edge ophthalmic diagnostic tools for the diagnosis of glaucoma, diabetic retinopathy, and macular degeneration. Their range of devices includes automated fundus imaging systems, perimeters, and handheld rebound tonometers, all designed to be fast, easy-to-use, and reliable. With their advanced technology and digital clinical tools, Centervue aims to establish the next level of eye care, making it accessible, effortless, and reliable for both physicians and patients.
Centervue's devices, such as their confocal fundus imaging systems and perimeters, capture ultra-high-quality images with TrueColor imaging and multiple modalities for higher accuracy. These computer-assisted devices are intuitive and require minimal staff training, resulting in reduced waiting time, efficient workflow, and improved patient comfort. Additionally, their handheld rebound tonometers provide quick and reliable intraocular pressure measurements, making glaucoma screening and monitoring more efficient. With a focus on innovation and optimized eye care, Centervue is at the forefront of ophthalmic technology.
Generated from the website